Sharon Chakkalackal of Toronto, Ont., was given a diagnosis she never expected — young-onset Parkinson’s disease. The nervous system condition is often associated with older people, but Parkinson ...
Blarcamesine’s safety profile indicates not requiring routine MRI monitoring, and the advantage of blarcamesine is that it is a small oral molecule that exerts clinical benefits on cognition and ...
Pathogenic mutations in LRRK2 account for 4-5% of familial and 1-2% of sporadic Parkinson’s disease. 1,2 BIIB122 (DNL151) is a selective, central nervous system-penetrant small molecule inhibitor of ...